PUBLISHER: QYResearch | PRODUCT CODE: 1867579
PUBLISHER: QYResearch | PRODUCT CODE: 1867579
The global market for E-Prescribing System was estimated to be worth US$ 3618 million in 2024 and is forecast to a readjusted size of US$ 11686 million by 2031 with a CAGR of 18.3% during the forecast period 2025-2031.
E-prescribing or electronic prescribing is a process involving the electronic generation and sending of prescription orders for the convenience of medical practitioners or physicians, allowing them to transmit prescriptions directly from the point of care to a pharmacy. E-prescribing enhances the safety of patients and the quality of care, since there is no manual writing involved and thus there is less probability of prescription errors. In addition, e-prescribing also helps conduct security checks, encapsulate medical lists, and compile the complete historical data of a patient.
With the continuous advancement of medical informatization, electronic prescription systems (e-prescribing systems) are rapidly gaining popularity worldwide, becoming a crucial tool for hospitals, pharmacies, and clinics to improve efficiency, reduce errors, and optimize patient management.
Key factors driving market growth include: First, policy support and regulatory support. Many European and American countries have incorporated e-prescribing into their healthcare oversight systems and have passed legislation to promote the deep integration of electronic health records (EHRs) and prescription systems, providing a solid foundation for the industry's development. Second, the demand for medical error prevention is increasing. E-prescribing systems, through drug databases, allergy warnings, and interaction detection, effectively reduce the risks associated with unclear handwriting or incorrect medication prescriptions. Third, the rise of telemedicine and mobile health has fueled demand for efficient, cloud-based, mobile-enabled prescription management systems, broadening their application scenarios.
However, market development still faces certain challenges. Tightening data privacy regulations, technical barriers to cross-platform system compatibility, and cost concerns among small and medium-sized medical institutions are currently the main obstacles to market adoption. Furthermore, developing countries still lack sufficient network infrastructure and medical staff training, which may limit market penetration in the short term. In terms of the current market landscape, North America holds a dominant position, boasting a relatively mature technology platform and healthcare system. Europe follows closely behind, with several countries promoting national e-prescription platforms. The Asia-Pacific region is the fastest-growing region, with policy guidance and the development of primary healthcare information technology in countries such as China, India, and Japan injecting new vitality into the market. Key market participants include Surescripts, Oracle, Veradigm, and Athenahealth, while also attracting numerous cloud service providers and medical AI startups.
In the future, e-prescription systems will evolve towards AI-assisted prescribing, personalized drug recommendations, and deep integration with automated medical insurance settlement systems. System intelligence, platform-based architecture, and interoperability will be key competitive drivers. As the global demand for efficient allocation of medical resources continues to rise, the e-prescription market will continue to unleash enormous potential in the digital health wave, becoming an indispensable component of smart healthcare.
This report aims to provide a comprehensive presentation of the global market for E-Prescribing System, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of E-Prescribing System by region & country, by Type, and by Application.
The E-Prescribing System market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding E-Prescribing System.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of E-Prescribing System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of E-Prescribing System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of E-Prescribing System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.